BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 22906662)

  • 1. Exploration of the correlations between interferon-γ in patient serum and HEPACAM in bladder transitional cell carcinoma, and the interferon-γ mechanism inhibiting BIU-87 proliferation.
    Xu B; He Y; Wu X; Luo C; Liu A; Zhang J
    J Urol; 2012 Oct; 188(4):1346-53. PubMed ID: 22906662
    [TBL] [Abstract][Full Text] [Related]  

  • 2. hepaCAM and p-mTOR closely correlate in bladder transitional cell carcinoma and hepaCAM expression inhibits proliferation via an AMPK/mTOR dependent pathway in human bladder cancer cells.
    Wang Q; Luo C; Wu X; Du H; Song X; Fan Y
    J Urol; 2013 Nov; 190(5):1912-8. PubMed ID: 23669565
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Influence of hepatocyte cell adhesion molecule on gene expression profile of human bladder transitional cell carcinoma cell line].
    Wang QJ; Lv CK; Tao J; Du HF; Fan YR; Song XD; Luo CL
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2013 Apr; 35(2):190-8. PubMed ID: 23643009
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 5-azacytidine inhibits the proliferation of bladder cancer cells via reversal of the aberrant hypermethylation of the hepaCAM gene.
    Wang X; Chen E; Yang X; Wang Y; Quan Z; Wu X; Luo C
    Oncol Rep; 2016 Mar; 35(3):1375-84. PubMed ID: 26677113
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of estrogen receptors-alpha and -beta in bladder cancer cell lines and human bladder tumor tissue.
    Shen SS; Smith CL; Hsieh JT; Yu J; Kim IY; Jian W; Sonpavde G; Ayala GE; Younes M; Lerner SP
    Cancer; 2006 Jun; 106(12):2610-6. PubMed ID: 16700038
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exon 2 methylation inhibits hepaCAM expression in transitional cell carcinoma of the bladder.
    Pan C; Wu X; Luo C; Yang S; Pu J; Wang C; Shen S
    Urol Int; 2010; 85(3):347-54. PubMed ID: 20628239
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional significance of the hepaCAM gene in bladder cancer.
    He Y; Wu X; Luo C; Wang L; Lin J
    BMC Cancer; 2010 Mar; 10():83. PubMed ID: 20205955
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of YC-1 on hypoxia-inducible factor 1 alpha in hypoxic human bladder transitional carcinoma cell line T24 cells.
    Li Y; Zhao X; Tang H; Zhong Z; Zhang L; Xu R; Li S; Wang Y
    Urol Int; 2012; 88(1):95-101. PubMed ID: 22041818
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cyclin D1 expression in transitional cell carcinoma of the bladder: correlation with p53, waf1, pRb and Ki67.
    Tut VM; Braithwaite KL; Angus B; Neal DE; Lunec J; Mellon JK
    Br J Cancer; 2001 Jan; 84(2):270-5. PubMed ID: 11161387
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The SMAD2/3 pathway is involved in hepaCAM-induced apoptosis by inhibiting the nuclear translocation of SMAD2/3 in bladder cancer cells.
    Wang X; Chen E; Tang M; Yang X; Wang Y; Quan Z; Wu X; Luo C
    Tumour Biol; 2016 Aug; 37(8):10731-43. PubMed ID: 26873485
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of hypermethylation in hepatocyte cell adhesion molecule gene promoter region in bladder carcinoma.
    Tao J; Liu Q; Wu X; Xu X; Zhang Y; Wang Q; Luo C
    Int J Med Sci; 2013; 10(13):1860-7. PubMed ID: 24324362
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Histone deacetylase inhibitor trichostatin A inhibits the growth of bladder cancer cells through induction of p21WAF1 and G1 cell cycle arrest.
    Li GC; Zhang X; Pan TJ; Chen Z; Ye ZQ
    Int J Urol; 2006 May; 13(5):581-6. PubMed ID: 16771729
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Urinary bladder transitional cell carcinogenesis is associated with down-regulation of NF1 tumor suppressor gene in vivo and in vitro.
    Aaltonen V; Boström PJ; Söderström KO; Hirvonen O; Tuukkanen J; Nurmi M; Laato M; Peltonen J
    Am J Pathol; 1999 Mar; 154(3):755-65. PubMed ID: 10079253
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incidence of apoptosis, cell proliferation and bcl-2 expression in transitional cell carcinoma of the bladder: association with tumor progression.
    King ED; Matteson J; Jacobs SC; Kyprianou N
    J Urol; 1996 Jan; 155(1):316-20. PubMed ID: 7490878
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adriamycin induced G2/M cell cycle arrest in transitional cell cancer cells with wt p53 and p21(WAF1/CIP1) genes.
    Bilim V; Kawasaki T; Takahashi K; Tomita Y
    J Exp Clin Cancer Res; 2000 Dec; 19(4):483-8. PubMed ID: 11277327
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of hepaCAM is downregulated in cancers and induces senescence-like growth arrest via a p53/p21-dependent pathway in human breast cancer cells.
    Moh MC; Zhang T; Lee LH; Shen S
    Carcinogenesis; 2008 Dec; 29(12):2298-305. PubMed ID: 18845560
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of the gene expression of SPARC and its prognostic value for bladder cancer.
    Yamanaka M; Kanda K; Li NC; Fukumori T; Oka N; Kanayama HO; Kagawa S
    J Urol; 2001 Dec; 166(6):2495-9. PubMed ID: 11696817
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interferon gamma regulates a unique set of proteins in fresh human bladder transitional cell carcinomas.
    Aboagye-Mathiesen G; Ebbesen P; von der Maase H; Celis JE
    Electrophoresis; 1999 Feb; 20(2):344-8. PubMed ID: 10197441
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction of G1 cell cycle arrest and apoptosis by berberine in bladder cancer cells.
    Yan K; Zhang C; Feng J; Hou L; Yan L; Zhou Z; Liu Z; Liu C; Fan Y; Zheng B; Xu Z
    Eur J Pharmacol; 2011 Jul; 661(1-3):1-7. PubMed ID: 21545798
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of the transcriptional activity of p53 improves the prediction of recurrence in superficial transitional cell carcinoma of the bladder.
    Dekairelle AF; Tombal B; Cosyns JP; Gala JL
    Clin Cancer Res; 2005 Jul; 11(13):4724-32. PubMed ID: 16000567
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.